TIMELINE OF ASSESSMENT
The table below shows the Timeline for Major Applications – General HTA track.
| HEALTH TECHNOLOGY | LAPATINIB FOR HER2(+) BC | PAZOPANIB | TACE WITH MITOMYCIN C | ZOLEDRONIC ACID | CEREBROLYSIN | INSULIN ANALOGUES | NEW OHA (DPP4 AND SGLT2 INHIBITORS: Sitagliptin and Dapagliflozin) | DEXAMETHASONE IMPLANT | DIRECT ORAL ANTICOAGULANTS | CITICOLINE | TIROFIBAN | TICAGRELOR (90 MG) | IVABRADINE |
| PROPONENT | Philippine Society of Medical Oncology (PSMO) | Philippine Society of Medical Oncology (PSMO) | Philippine Society of Vascular and Interventional Radiology (PSVIR) | National Kidney and Transplant Institute (nkti) | Stroke Society of the Philippines (SSP) | Philippine Society of Endocrinology Diabetes and Metabolism (PSEDM) | Philippine Society of Endocrinology Diabetes and Metabolism (PSEDM) | Philippine Academy of Ophthalmology (PAO) | Philippine Neurological Association (PNA) | Philippine Neurological Association (PNA) | Philippine Society of Cardiovascular Catheterization, Inc. (PSCCI) | Philippine Society of Cardiovascular Catheterization, Inc. (PHC) | Philippine Heart Center (PHA) |
| TOPIC NOMINATION | |||||||||||||
| TOPIC PRIORITIZATION | |||||||||||||
| SCOPING | |||||||||||||
| PROTOCOL DEVELOPMENT | |||||||||||||
| CLINICAL ASSESSMENT | |||||||||||||
| ECONOMIC ASSESSMENT | |||||||||||||
| EVIDENCE APPRAISAL | |||||||||||||
| RECOMMENDATION | |||||||||||||
| APPEALS | |||||||||||||
| RESOLUTION | |||||||||||||
| DECISION OF THE SECRETARY OF HEALTH | |||||||||||||
| DISSEMINATION | Link to Evidence Summary |